Merck blamed the move on a lack of investment in the industry by the UK

Merck blamed the move on a lack of investment in the industry by the UK

 SPENCER PLATT

Merck, the US pharmaceutical group, said on Wednesday it has dropped plans to build a $1.4-billion research centre in Britain, blaming the country's "lack of investment" in the sector and its drugs prices.

The company said in a statement it would not go through with the construction, which had been slated for the King's Cross district in central north London.

Originally published on doc.afp.com, part of the BLOX Digital Content Exchange.

Tags

Recommended for you